June 18, 2020 10:32 AM EDT
News Briefing

Ab­b­Vie’s Rin­voq pass­es PhI­II AD test; Dicer­na races Al­ny­lam; New Sarep­ta gene & cell col­lab

Jason Mast

Editor

→ Al­most a year af­ter it was ap­proved for rheuma­toid arthri­tis, Ab­b­Vie’s JAK in­hibitor Rin­voq was shown for the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er hires ex-FDA deputy Pa­trizia Cavaz­zoni as chief med­ical of­fi­cer

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Sanofi, Te­va bol­ster case for IBD drug with Phase 2 da­ta, de­spite po­ten­tial com­pe­ti­tion

FDA lifts hold on En­trada's Duchenne drug af­ter two years

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times